Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
An immunotoxin and single-chain antibody technology, which is applied in the biological field to achieve obvious effects, simple and convenient preparation, and small toxic and side effects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Preparation of the fusion toxin of the present invention
[0024] The heavy and light chain variable regions of antibodies were amplified from known anti-EGFR hybridomas to construct anti-EGFR single-chain antibodies, which were specifically identified and affinity evolved using ribosome display technology. A fusion gene was constructed between Gelonin and the obtained single-chain antibody gene, and then expressed in E. coli.
[0025] Specifically: extract total RNA from anti-EGFR hybridoma cells (preserved in our laboratory), and then amplify the heavy and light chains (VH, VL) of Anti-EGFR by RT-PCR according to the designed library and specific primers Gene, select the band with good amplification effect for gel recovery, and insert into T vector. The ligation product was transformed into DH5a, a large number of single colonies were picked, the plasmid was extracted, and sent for sequencing. The sequencing results were analyzed by Jellyfish software, and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com